TY - JOUR
T1 - Robotic vs. open cystectomy
T2 - How length-of-stay differences relate conditionally to age
AU - Faraj, Kassem
AU - Chang, Yu Hui H.
AU - Neville, Matthew R.
AU - Blodgett, Gail
AU - Etzioni, David A.
AU - Habermann, Elizabeth B.
AU - Andrews, Paul E.
AU - Castle, Erik P.
AU - Humphreys, Mitchell R.
AU - Tyson, Mark D.
N1 - Funding Information:
Funding Sources: This study was generously supported by funding from the Robert D. and Patricia E. Kern Center for Health Care Delivery Science (M.D.T., D.A.E., E.B.H., Y.H.C.), the Christian Haub Family Career Development Award for Cancer Research honoring Dr. Richard Emslander (M.D.T.), and the Eric and Gail Blodgett Foundation (M.D.T.).
Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/6
Y1 - 2019/6
N2 - Objectives: The length-of-stay (LOS)benefit of minimally invasive cystectomy varies in the published literature, potentially because of subgroup effects. Here, we investigated the effect of minimally invasive cystectomy on LOS among different age groups. Methods and materials: Adult patients who underwent cystectomy (open or minimally invasive)from January 1, 2012, to December 31, 2016, were identified from the National Surgical Quality Improvement Program database. Multivariable linear regression was used to evaluate the adjusted association between the surgical approach and LOS after stratifying patients by age (40–64, 65–79, and ≥80 years). A sensitivity analysis was performed after multiple imputation by using age as a continuous variable with a third-order polynomial term. Results: Of the 5,561 patients identified, 640 underwent minimally invasive cystectomy and 4,921 had open cystectomy. The unadjusted analysis showed that minimally invasive cystectomy was associated with a shorter mean LOS compared with the open approach (8.0 vs. 9.7 days; P < 0.001). The predicted difference in LOS between the 2 approaches was 0.72 days (95% confidence interval (CI), −0.28 to 1.72; P = 0.16)for patients aged 40 to 64 years, 1.48 days (95% CI, 0.73–2.23; P < 0.001)for 65 to 79 years, and 2.56 days (95% CI, 0.84–4.29; P = 0.01)for ≥80 years favoring the minimally invasive approach. The sensitivity analysis did not materially change the results. Conclusions: Older patients may derive more LOS benefit from minimally invasive approaches than younger patients. Given the greater expense associated with the minimally invasive approach, an age-adapted strategy to using this technology may be reasonable.
AB - Objectives: The length-of-stay (LOS)benefit of minimally invasive cystectomy varies in the published literature, potentially because of subgroup effects. Here, we investigated the effect of minimally invasive cystectomy on LOS among different age groups. Methods and materials: Adult patients who underwent cystectomy (open or minimally invasive)from January 1, 2012, to December 31, 2016, were identified from the National Surgical Quality Improvement Program database. Multivariable linear regression was used to evaluate the adjusted association between the surgical approach and LOS after stratifying patients by age (40–64, 65–79, and ≥80 years). A sensitivity analysis was performed after multiple imputation by using age as a continuous variable with a third-order polynomial term. Results: Of the 5,561 patients identified, 640 underwent minimally invasive cystectomy and 4,921 had open cystectomy. The unadjusted analysis showed that minimally invasive cystectomy was associated with a shorter mean LOS compared with the open approach (8.0 vs. 9.7 days; P < 0.001). The predicted difference in LOS between the 2 approaches was 0.72 days (95% confidence interval (CI), −0.28 to 1.72; P = 0.16)for patients aged 40 to 64 years, 1.48 days (95% CI, 0.73–2.23; P < 0.001)for 65 to 79 years, and 2.56 days (95% CI, 0.84–4.29; P = 0.01)for ≥80 years favoring the minimally invasive approach. The sensitivity analysis did not materially change the results. Conclusions: Older patients may derive more LOS benefit from minimally invasive approaches than younger patients. Given the greater expense associated with the minimally invasive approach, an age-adapted strategy to using this technology may be reasonable.
KW - Bladder cancer
KW - Cystectomy
KW - Length of stay
KW - Robotic surgery procedures
UR - http://www.scopus.com/inward/record.url?scp=85061356290&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061356290&partnerID=8YFLogxK
U2 - 10.1016/j.urolonc.2019.01.028
DO - 10.1016/j.urolonc.2019.01.028
M3 - Article
C2 - 30770298
AN - SCOPUS:85061356290
SN - 1078-1439
VL - 37
SP - 354.e1-354.e8
JO - Urologic Oncology: Seminars and Original Investigations
JF - Urologic Oncology: Seminars and Original Investigations
IS - 6
ER -